Determinants of natriuretic peptide gene expression

Area of Science:

• Cardiovascular Physiology
• Endocrinology
• Renal Physiology

Background:

• Cardiac natriuretic peptides (NPs), specifically atrial natriuretic factor (ANF) and brain natriuretic peptide (BNP), are synthesized and secreted by atrial cardiocytes.
• These NPs are stored in specific atrial granules and play crucial roles in regulating renal mechanisms, sympathetic nervous system activity, and the renin-angiotensin-aldosterone system (RAAS).
• NPs influence fluid volume, vascular tone, and overall renal function.

Purpose of the Study:

• To investigate the distinct mechanisms controlling the synthesis and secretion of ANF from atrial cardiocytes.
• To differentiate between baseline and stimulated NP secretion pathways.
• To elucidate the roles of stretch-stimulation and Gq-mediated signaling in NP release.

Main Methods:

• Analysis of regulated secretory processes in atrial cardiocytes.
• Investigation of pertussis toxin (PTX) sensitivity in different secretory pathways.
• Examination of Gq-mediated signaling pathways.
• In vivo correlation of secretory mechanisms with physiological conditions like fluid volume expansion and congestive heart failure.

Main Results:

• Two primary regulated secretory processes for ANF were identified in atrial cardiocytes.
• One pathway is sensitive to stretch stimulation and pertussis toxin (PTX).
• A second pathway is Gq-mediated and PTX-insensitive; baseline ANF secretion is also PTX-insensitive.

Conclusions:

• Stretch-stimulated ANF secretion, mediated by a PTX-sensitive pathway, is likely involved in responses to acute fluid volume expansion.
• Gq-mediated, PTX-insensitive signaling may underlie ANF secretion during sustained hemodynamic and neuroendocrine stimuli, as seen in congestive heart failure.
• These findings highlight distinct cellular mechanisms governing NP release in response to different physiological challenges.